Stockhead’s Fraser Palamara sits down with Island Pharmaceuticals (ASX:ILA)  CEO and managing director David Foster to get the short end of the long story on the company’s latest news.

Congress unveiled its second guarantee on Wednesday, announcing up to a Rs 25-lakh health insurance cover through a proposed Jeevan Raksha .

Progression to the phase 2b cohort follows recommendation of the Safety Review Committee (SRC) after it reviewed positive ...

Island Pharmaceuticals Ltd (ASX:ILA) has successfully enrolled its first subjects for a Phase 2b clinical trial to test the ...

Dual-listed regenerative medicine company Avita Medical has seen its share price slide ~19% today on a downgrade of its ...

The Pune Municipal Corporation (PMC) only recorded as confirmed dengue cases people who tested positive via the IgM ELISA and ...

What's one thing humankind can do to help heal the world? The wishes cover everything from upholding Jimmy Carter's legacy to ...

“The charge for a fever consultation at a private clinic can now reach RM120 to RM150, which is very burdensome. And that is ...

Some diseases that have spread over the last few decades are untreatable with medicines. Recovery banks heavily on immunity & ...

The dengue outbreak in Bangladesh remains a significant public health challenge, with recent data revealing 67 ...

Dengue, malaria, Japanese encephalitis and kala azar killed 285 people in 2024, as per data from the NCVBDC. A vaccine was discovered for dengue, and new techniques for vector management that aim to ...

As 2024 approaches its end, a regrettable roundup of the performance of the Sindh government in the domain of public health ...